ZAWYA-PRESSR: Johns Hopkins Aramco Healthcare to partner in inaugural Applied Medical Research and Innovation Forum in Dammam
SAUDI ARAMCO 2222.SA | 27.60 | +0.15% |
- The partnership reflects JHAH’s commitment to continuous learning and innovation, translating scientific discoveries into real-world healthcare solutions.
Dammam, Saudi Arabia: Johns Hopkins Aramco Healthcare (JHAH) is supporting the inaugural Applied Medical Research and Innovation Forum, organized by Imam Abdulrahman Bin Faisal University, taking place from February 10 to 11, 2026, under the theme, “Where Disciplines Meet: Shaping the Future of Healthcare”.
JHAH’s support for the forum underscores its longstanding commitment to excellence in patient-centered care, while strengthening the Kingdom’s research capabilities and promoting evidence-based practice. Aligned with the objectives of Saudi Vision 2030, the partnership also seeks to foster sustainable healthcare innovation and cultivate the next generation of healthcare leaders.
Participants will engage in dynamic scientific discussions that advance applied medical research and fuel innovative solutions for the future of healthcare. Dr. Russell Hales, Chief of Centres of Excellence at JHAH, will participate in a leadership panel focused on advancing multidisciplinary healthcare research and translating scientific discovery into practical healthcare impact.
JHAH will also contribute to the forum’s applied research agenda through a workshop led by Dr. Hayat S. Al Mushcab, Manager of the Research Office, focusing on strategies to enhance research excellence through cross-disciplinary collaboration.
Dr. Howard S. Podolsky, Chief Executive Officer of Johns Hopkins Aramco Healthcare, said: “We are proud to support the launch of the Applied Medical Research and Innovation Forum, a platform where ideas from various disciplines can come together to shape the future of healthcare. This partnership provides an invaluable opportunity to collaborate with leading voices from healthcare delivery, innovation, and academic research, building on JHAH’s own model of integrated excellence in care and discovery. Together, we aim to prompt new lines of inquiry, galvanize the pace of innovation, and ultimately support the overall well-being of communities across the Kingdom.”
This first Applied Medical Research and Innovation Forum is a significant milestone in nurturing collaboration between critical factions of the healthcare industry. Through their shared efforts, the event is poised to strengthen the Kingdom’s position as a regional leader in medical innovation while advancing knowledge exchange and stimulating pioneering healthcare solutions.
About Johns Hopkins Aramco Healthcare
Johns Hopkins Aramco Healthcare (JHAH) is a top healthcare provider, founded in 2014 as a joint venture between Saudi Aramco and Johns Hopkins Medicine (JHM). The decade-long partnership combines Saudi Aramco’s trusted medical history, dating back to the Saudi Aramco Medical Services Organization (SAMSO) since 1945, with JHM’s global leadership in clinical innovation, cutting-edge medical research, and world-class medical education.
JHAH provides world-class, patient-centered care across multiple specialties, including Centers of Excellence in cardiology, oncology, urology, robotic urology, mental health, ENT, gastrointestinal, ophthalmology, allergy, and immunology, among others. Leveraging Saudi Aramco’s resources and JHM’s expertise, JHAH integrates innovative care models, including remote medicine, hospital-at-home, and AI-powered diagnostics, to deliver technology-driven, inclusive, and accessible care tailored to each patient’s needs. By advancing precision medicine, encouraging digital healthcare innovation, and cultivating a skilled national workforce, JHAH continues to meet the evolving healthcare needs of the communities it serves. For more information, please visit the website: www.jhah.com
For media inquiries, please contact:
Mahmoud Abu-Rob
Mahmoud.Abu-Rob@bursonglobal.co
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.